PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
NVIV vs. FAT
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between NVIV and FAT is 0.08, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.1

Performance

NVIV vs. FAT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in InVivo Therapeutics Holdings Corp. (NVIV) and FAT Brands Inc. (FAT). The values are adjusted to include any dividend payments, if applicable.

-100.00%-50.00%0.00%50.00%SeptemberOctoberNovemberDecember2025February
-100.00%
37.68%
NVIV
FAT

Key characteristics

Fundamentals

Market Cap

NVIV:

$995.92K

FAT:

$67.89M

EPS

NVIV:

-$3.28

FAT:

-$9.22

Returns By Period


NVIV

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

FAT

YTD

30.90%

1M

26.85%

6M

37.69%

1Y

-14.05%

5Y*

40.80%

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

NVIV vs. FAT — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NVIV

FAT
The Risk-Adjusted Performance Rank of FAT is 3131
Overall Rank
The Sharpe Ratio Rank of FAT is 3030
Sharpe Ratio Rank
The Sortino Ratio Rank of FAT is 2929
Sortino Ratio Rank
The Omega Ratio Rank of FAT is 2929
Omega Ratio Rank
The Calmar Ratio Rank of FAT is 2929
Calmar Ratio Rank
The Martin Ratio Rank of FAT is 3636
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

NVIV vs. FAT - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for InVivo Therapeutics Holdings Corp. (NVIV) and FAT Brands Inc. (FAT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
No data
The chart of Calmar ratio for NVIV, currently valued at 0.00, compared to the broader market0.002.004.006.000.00-0.26
NVIV
FAT


Rolling 12-month Sharpe Ratio-1.00-0.500.00SeptemberOctoberNovemberDecember2025February
-1.00
-0.28
NVIV
FAT

Dividends

NVIV vs. FAT - Dividend Comparison

NVIV has not paid dividends to shareholders, while FAT's dividend yield for the trailing twelve months is around 7.63%.


TTM2024202320222021202020192018
NVIV
InVivo Therapeutics Holdings Corp.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
FAT
FAT Brands Inc.
7.63%12.62%9.25%13.17%8.81%0.00%11.43%23.89%

Drawdowns

NVIV vs. FAT - Drawdown Comparison


-100.00%-80.00%-60.00%-40.00%-20.00%SeptemberOctoberNovemberDecember2025February
-100.00%
-25.00%
NVIV
FAT

Volatility

NVIV vs. FAT - Volatility Comparison

The current volatility for InVivo Therapeutics Holdings Corp. (NVIV) is 0.00%, while FAT Brands Inc. (FAT) has a volatility of 21.93%. This indicates that NVIV experiences smaller price fluctuations and is considered to be less risky than FAT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%SeptemberOctoberNovemberDecember2025February0
21.93%
NVIV
FAT

Financials

NVIV vs. FAT - Financials Comparison

This section allows you to compare key financial metrics between InVivo Therapeutics Holdings Corp. and FAT Brands Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab